Chemistry is the ‘central science’ – a foundational scientific discipline that is critical to solving many of the world’s most pressing problems. At Providence College, we provide our students the tools to satisfy their natural curiosity about the world and explore wherever their interests lead them.
Chemistry is a vital component of the STEM [Science, Technology, Engineering, and Mathematics] fields that have experienced growing employment opportunities and increasing salaries for decades. Our programs train students to hit the ground running by providing a comprehensive grounding in the fundamentals of chemistry and biochemistry.
In the past few years our alumni have entered graduate programs at prestigious schools, including Cal-Berkeley, Columbia, Northwestern, Princeton, the University of Pennsylvania, and Yale. Other alumni have entered medical school at Brown, Tulane, UConn, USUHS, and Wake Forrest, dental school at Tufts, and pharmacy school at the MCPHS. Still others found employment at Merck, Hanna Instruments, and Organogenesis.
On paper, Eddie Martucci ’04 is a biochemist. He earned three degrees – a bachelor’s from PC and a master’s and Ph.D. from Yale – all in biochemistry. But in
practice, Martucci is an alchemist of sorts – an entrepreneur, venture capitalist, and scientist who combines seemingly dissimilar specialties to create biomedical breakthroughs.
In 2009, he joined PureTech, and incubator and think tank that seeks out “the best scientists in the world working on the best technologies” that have the potential to transform patient’s lives. In 2012, he founded Akili Interactive, a “digital medicine” company that has hired top video game designers, biomedical and biochemical engineers, neuroscientists, and business minds to create apps with the potential to treat ADHD and autism.
“At the time, this was a ridiculously crazy idea,” Martucci recalls. “I was trained very early to take an interdisciplinary approach to any problem. It’s the only way to be successful in the startup environment. If you drop all of the politics and preconceptions of what certain disciplines of science do better than others, you’ll discover the best way to solve problems scientifically.”
Clearly, he’s on to something. In 2016, Akili was ranked No. 1 in the healthcare category of
magazine’s 100 Brilliant Companies to Watch and has attracted the attention of Pfizer, Shire Pharmaceuticals, and Autism Speaks.
“At PC, they do a really great thing. In your junior and senior year, you dive into the scientific literature and new research and then present this fascinating new area of research to the department. It’s open-book. You can do anything you want. And I think that’s reflective of PC generally – you’re encouraged not to have too many preconceptions. You’re encouraged to find something interesting with no predefined boxes. I still remember that intensely.”
PC recently received its first major grant award from the Clare Boothe Luce Program at the Henry Luce Foundation. The award will support eight Clare Boothe Luce Undergraduate Scholarships in chemistry, applied physics, mathematics, or computer science for exceptional senior female students.
The American Chemical Society accredits the Department of Chemistry and Biochemistry, along with its bachelors of science degrees in chemistry and biochemistry.
“Research is really dynamic, it’s constantly ebbing and flowing. I tell my research students all the time that 95 percent of everything that they are going to do in the lab will probably fail. But, it’s in learning from these failures and trying to find the elusive five percent that makes everything worthwhile. Sometimes we need to take two steps back in order to take one step forward. It’s experiencing this kind of success that actually makes it worthwhile to go back and address a new problem with even more excitement.”
Dr. Seann MulcahyAssociate Professor of Chemistry